NeuPath Health: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (NPTH)
NeuPath Health is now ranked among the top 10 undervalued stocks in the Healthcare sector on the TSX Venture Exchange.
- A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
- Valuation methodology provided by Stockcalc (see below)
Stocks in this category are held primarily for capital appreciation.
| Symbol | Name | Close Price ($) | Valuation ($) | Difference | Average Vol (30D) | Market Cap ($M) | Yield (%) | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
| KOVO | Kovo Healthtech | 0.04 | 0.14 | 0.09 (207.4%) | 23431 | 2.6 | 0.0 | 0.0 |
| PSYB | PsyBio Therapeutics | 0.01 | 0.03 | 0.02 (190.4%) | 1.3 | 0.0 | 0.0 | |
| LFST | Lifeist Wellness | 0.01 | 0.03 | 0.02 (163.1%) | 717480 | 4.7 | 0.0 | 0.0 |
| BTI | Bioasis Technologies | 0.01 | 0.01 | 0.01 (160.3%) | 72282 | 0.4 | 0.0 | 0.0 |
| VIV | Avivagen | 0.01 | 0.01 | 0.01 (155.8%) | 46328 | 0.4 | 0.0 | 0.0 |
| NPTH | NeuPath Health | 0.18 | 0.38 | 0.20 (113.7%) | 9694 | 10.2 | 0.0 | 0.0 |
| QPT | Quest PharmaTech | 0.03 | 0.05 | 0.02 (94.0%) | 45848 | 4.2 | 0.0 | 0.0 |
| JNH | Jack Nathan Medical | 0.06 | 0.11 | 0.05 (75.2%) | 37479 | 5.4 | 0.0 | 0.0 |
| HEM | Hemostemix | 0.08 | 0.14 | 0.06 (72.3%) | 37090 | 6.8 | 0.0 | 0.0 |
| HMPG | Hempshire Gr | 0.01 | 0.01 | 0.00 (66.1%) | 31194 | 0.4 | 0.0 | 0.0 |
All data provided as of February 16, 2024.
The list is sorted by stocks with the greatest percentage difference between valuation and price.
NeuPath Health
NeuPath Health Inc operates an end-to-end, integrated network of healthcare businesses. It utilizes research, data-driven insights, technology, and interdisciplinary care to help restore function for patients impacted by acute and chronic musculoskeletal conditions, including chronic pain, spinal injuries, sports-related injuries, and concussions.
NeuPath Health is listed under NPTH on the TSX Venture Exchange.
Stockcalc
StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.
Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:
- Discounted Cash Flow (DCF)
- Price & Other Comparables
- Multiples
- Adjusted Book Value (ABV)
- Analyst Consensus
Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
